Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report
2013 ◽
Vol 15
(3)
◽
pp. 299-311
◽
Keyword(s):
2020 ◽
Vol 32
(1)
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 403
(1)
◽
pp. 227-238
◽